High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy

Neoadjuvant chemotherapy (NAC) is a widely-used treatment for breast cancer, as it may render unresectable breast tumors to become resectable. In addition, NAC provides the unique opportunity to assess response to treatments within months rather than years of follow-up. However, predictive markers o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rau, Kun-Ming, Su, Yu-Li, Li, Shan-Hsuan, Hsieh, Meng-Che, Wu, Shis-Chung, Chou, Fong-Fu, Chiu, Tai-Jan, Chen, Yen-Hao, Liu, Chien-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865844/
https://www.ncbi.nlm.nih.gov/pubmed/28944897
http://dx.doi.org/10.3892/mmr.2017.7555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865844/
https://www.ncbi.nlm.nih.gov/pubmed/28944897
http://dx.doi.org/10.3892/mmr.2017.7555

Ejemplares similares